Xiaofei Lai
Impact in
-
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
-
- Sepsis Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
-
- Antifungal resistance and susceptibility 4
- Clostridium difficile and Clostridium perfringens research 4
- Epidemiology 12
- Sepsis Diagnosis and Treatment 8
- Hepatitis B Virus Studies 2
- Pneumonia and Respiratory Infections 2
- Co-authors
- Ju Cao (20 shared papers)Yu Xiang (7 shared papers)Liping Zhang (5 shared papers)Yi Liu (9 shared papers)Fang Xu (5 shared papers)Huiqing Yang (4 shared papers)Shihui Lin (1 shared paper)Yibing Yin (4 shared papers)
- Journals
- Molecules (2 papers)Science Translational Medicine (2 papers)Clinical and Experimental Rheumatology (2 papers)International Immunopharmacology (2 papers)PLoS Pathogens (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaofei Lai
30 papers receiving 319 citations
Peers
Comparison fields: 5 of 55
- Rheumatology 44
- Epidemiology 80
- Immunology 42
- Hepatology 15
- Oncology 34
Countries citing papers authored by Xiaofei Lai
This map shows the geographic impact of Xiaofei Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Lai more than expected).
Fields of papers citing papers by Xiaofei Lai
This network shows the impact of papers produced by Xiaofei Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Lai. The network helps show where Xiaofei Lai may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofei Lai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 37 | |
| 2 | 2015 | 35 | |
| 3 | 2016 | 35 | |
| 4 | 2019 | 29 | |
| 5 | 2018 | 21 | |
| 6 | 2011 | 18 | |
| 7 | 2024 | 18 | |
| 8 | 2022 | 17 | |
| 9 | 2022 | 16 | |
| 10 | 2013 | 10 | |
| 11 | 2018 | 10 | |
| 12 | 2019 | 9 | |
| 13 | 2021 | 8 | |
| 14 | 2021 | 8 | |
| 15 | 2022 | 8 | |
| 16 | 2021 | 6 | |
| 17 | 2022 | 6 | |
| 18 | 2021 | 5 | |
| 19 | 2023 | 5 | |
| 20 | 2012 | 4 |
About Xiaofei Lai
Xiaofei Lai is a scholar working on Infectious Diseases, Epidemiology, Rheumatology, Hepatology and Immunology, having authored 34 papers that have together received 328 indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (8 papers), Antifungal resistance and susceptibility (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Clostridium difficile and Clostridium perfringens research (4 papers), Hepatitis B Virus Studies (2 papers), Pneumonia and Respiratory Infections (2 papers), Inflammation biomarkers and pathways (2 papers) and Systemic Lupus Erythematosus Research (2 papers). The work is most often cited by research in Rheumatology (44 citations), Epidemiology (80 citations), Immunology (42 citations), Hepatology (15 citations) and Oncology (34 citations). Xiaofei Lai has collaborated with scholars based in China and United States. Frequent co-authors include Ju Cao, Yu Xiang, Liping Zhang, Yi Liu, Fang Xu, Huiqing Yang, Shihui Lin, Yibing Yin, Yan Luo and Jiaxi Li. Their work appears in journals such as Molecules, Science Translational Medicine, Clinical and Experimental Rheumatology, International Immunopharmacology and PLoS Pathogens.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.